Sign in

CIK 0000310158

  • Large accelerated filer

Merck & Co., Inc.

Sign in to watch
Ticker
MRK
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
EIN
221918501
Phone
+1 908-740-4000
Business address
126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
Former names
Merck & Co. Inc., SCHERING PLOUGH CORP
  1. 4 Open-market sale Executive VP & President, MRL sold 14,702 shares at $125.50 ($1,845,083)
  2. 4 Open-market sale EVP,Chief Info&Digital Officer sold 1,451 shares at $127.57 ($185,108)
  3. 4 Open-market sale President, U.S. Market sold 18,959 shares at $127.18 ($2,411,111)
  4. 4 Open-market sale EVP, Chief HR Officer sold 50,694 shares at $126.65 ($6,420,349)
  5. 4 Open-market sale EVP, General Counsel sold 49,499 shares at $126.97 ($6,284,779)
  6. 4 Grant or award President, U.S. Market acquired 3,133 shares (grant or award)
  7. 4 Grant or award SVP Fin. - Global Controller acquired 2,661 shares (grant or award)
  8. 4 Grant or award EVP,Chief Info&Digital Officer acquired 10,196 shares (grant or award)
  9. 4 Grant or award EVP, Chief HR Officer acquired 18,384 shares (grant or award)
  10. 4 Grant or award EVP, General Counsel acquired 23,298 shares (grant or award)
  11. 4 Grant or award Executive VP & President, MRL acquired 25,760 shares (grant or award)
  12. 4 Grant or award Chairman, CEO & President acquired 76,510 shares (grant or award)
  13. 4 Grant or award EVP&Pres, Merck Animal Heallth acquired 23,296 shares (grant or award)
  14. 4 Grant or award Exe V-P & Pres. MMD acquired 26,716 shares (grant or award)
  15. 4 Grant or award EVP & CFO acquired 19,208 shares (grant or award)
  16. 4 Grant or award EVP - Chief Strategy Officer acquired 3,896 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 11 of 99 · 1,973 filings